Pharmafile Logo

News and Press Releases

Quidditas raises €2.62M to accelerate development of pioneering genome editing technology

Funding will enable company to expand research capacity and scale up unique genome editing technology designed to treat complex, rare diseases while also opening new avenues for protein bioproduction and...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: May 12, 2025

Quidditas Therapeutics
contact@quidditastherapeutics.com
23, rue des bourguignons 91310 MONTLHERY

CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform

Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development 24 April 2025 -- Cambridge, UK -- CN Bio,...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 24, 2025

CN-Bio
enquiries@cn-bio.com
30 Upper High Street, Thame, Oxfordshire, OX9 3EZ

Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers

23 April 2025 -- Ingelheim, Germany and Amsterdam, the Netherlands -- Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2025

Boehringer Ingelheim
Binger Strasse 173 55216 Ingelheim am Rhein

Pistoia Alliance Launches Initiative to Assess Sustainability of Digital vs. Traditional Clinical Trial Approaches

New initiative will collect pharma and CRO data to refine industry carbon measurement of technologies like remote monitoring and eConsent, informing more sustainable trial design 20 March 2025, Massachusetts, US...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 20, 2025

The Pistoia Alliance
info@pistoiaalliance.org
401 Edgewater Pl, Wakefield, Massachusetts, US

GILEAD AND LEO PHARMA ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF ORAL STAT6 PROGRAM WITHPOTENTIAL IN MULTIPLE INFLAMMATORY DISEASES

11 January 2025 – Foster City, California, US and Ballerup, Denmark – Gilead Sciences, Inc. (Nasdaq: GILD) andLEO Pharmatoday announced a strategic partnership to accelerate the development and commercialization of...

Category: Pharmaceutical
Posted: January 13, 2025

Gilead Sciences, Inc

VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

Joint licensing agreement to commercialize ready-to-conjugate vaccine carrier protein CRM197 will enable rapid development of conjugate vaccines 29 October 2024 -- Klosterneuburg, Austria, and Maryland, US -- VALANX Biotech, a...

Category: BioManufacturing, Biotechnology, Drug Delivery, Pharmaceutical
Posted: October 29, 2024

VALANX Biotech
sarah.jeffery@zymecommunications.com
VALANX Biotech Gmbh, Plöcking 1, IST Park Building, 3400 Klosterneuburg, Austria

Publication Demonstrates Potential for Multi-Marker CTC Profiling in Early Prostate Cancer

Parsortix enriched CTCs detected at high rates in localised disease Multi-marker profiling of CTCs could support development of targeted therapies and help stratify patients in clinical trials 17 October 2024...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 17, 2024

ANGLE plc
2 Occam Court, Occam Road, Surrey Research Park, Guilford, GU2 7QB

Mosaic Therapeutics appoints Dr Barry Davies as CSO

Former AstraZeneca Senior Director, Global Project Leader adds significant experience and expertise to leadership team Appointment will drive further development of Mosaic’s targeted oncology combination therapies pipeline and platform. 7...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 7, 2024

Mosaic Therapeutics
info@mosaic-tx.com
Mosaic Therapeutics Wellcome Genome Campus Cambridge CB10 1DR

Plexium Selects Xavo as their Sample Management Lab Operations Platform

24 July 2024 -- Massachusetts, US -- Xavo, a leading provider of innovative software solutions for life sciences R&D, proudly announces Plexium as its latest esteemed client. “We are thrilled...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 24, 2024

Xavo
One Boston Place, Suite 2600 Boston, MA 02108, USA

Pistoia Alliance Research Finds 77% of Researchers Not Using In Vitro Alternatives to Animal Testing, as it Launches Non-Animal Models Community

Alliance calls on experts to join its new collaborative community, seeking to overcome regulatory and data challenges preventing the replacement and reduction of animal testing 11 July 2024 -- Boston,...

Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 11, 2024

The Pistoia Alliance
info@pistoiaalliance.org
401 Edgewater Pl, Wakefield, Massachusetts, US

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials 5 June 2024 -- Pennsylvania, US -- CluePoints, providers...

Category: Biotechnology, Pharmaceutical
Posted: June 5, 2024

CluePoints
contact@cluepoints.com
1000 Continental Drive, Suite 240, King of Prussia, PA 19406

NEOsphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery

14 May 2024 -- Martinsried, Germany -- NEOsphere Biotechnologies, a German biotechnology company pioneering high-throughput proteomics to systematically build broad and unique portfolios of novel degrader targets at scale, today...

Category: Drug Discovery, Pharmaceutical
Posted: May 14, 2024

NEOsphere Biotechnologies
info@neospherebiotech.com
Fraunhoferstrasse 1 82152 Planegg Germany